tiprankstipranks

Investments - New Portfolio

Michael Klugmann

Investments
Individual Investor
Ranked #609,433 out of 723,149 TipRanks' Investors
Success Rate
21%
33 out of 157
profitable transactions
Average Return
-43.54%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 19.21%
6-Month Return▲ 31.82%
12-Month Return▼ 26.56%
YTD Return▲ 19.39%
Total Return▼ 87.26%

Best Trade

Opened at
Closed at
Gain▲ 229.17%

Bio

High intensity R&D 2 MC with Qualitative analysis

Performance

43.87%0-43.87%
▼ 8.63%
▼ 1.63%
▼ 13.61%
Aug 2023
▼ 4.52%
▼ 4.74%
▼ 21.40%
Sep 2023
▼ 6.45%
▼ 2.17%
▼ 7.99%
Oct 2023
▲ 9.22%
▲ 9.13%
▲ 12.37%
Nov 2023
▲ 5.14%
▲ 4.57%
▲ 10.34%
Dec 2023
▼ 1.87%
▲ 1.59%
▲ 1.73%
Jan 2024
▲ 14.08%
▲ 5.22%
▲ 43.87%
Feb 2024
▲ 2.73%
▲ 2.43%
▼ 18.43%
Mar 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 8.63%▼ 1.63%▼ 13.61%
▼ 4.52%▼ 4.74%▼ 21.40%
▼ 6.45%▼ 2.17%▼ 7.99%
▲ 9.22%▲ 9.13%▲ 12.37%
▲ 5.14%▲ 4.57%▲ 10.34%
▼ 1.87%▲ 1.59%▲ 1.73%
▲ 14.08%▲ 5.22%▲ 43.87%
▲ 2.73%▲ 2.43%▼ 18.43%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
ja92n1c
ja92n1c
ja92n1c
ja92n1c
ja92n1c
ja92n1c
ja92n1c
hvy61ow0q04
hvy61ow0q04
hvy61ow0q04
hvy61ow0q04
hvy61ow0q04
hvy61ow0q04
hvy61ow0q04
ssfazx
ssfazx
ssfazx
ssfazx
ssfazx
ssfazx
ssfazx
0xpd84tg3r48
0xpd84tg3r48
0xpd84tg3r48
0xpd84tg3r48
0xpd84tg3r48
0xpd84tg3r48
0xpd84tg3r48
mgyd5rt
mgyd5rt
mgyd5rt
mgyd5rt
mgyd5rt
mgyd5rt
mgyd5rt
jnpiomgqzy
jnpiomgqzy
jnpiomgqzy
jnpiomgqzy
jnpiomgqzy
jnpiomgqzy
jnpiomgqzy
eueyi3769aw
eueyi3769aw
eueyi3769aw
eueyi3769aw
eueyi3769aw
eueyi3769aw
eueyi3769aw
uamak05
uamak05
uamak05
uamak05
uamak05
uamak05
uamak05
bxvq3ei894q
bxvq3ei894q
bxvq3ei894q
bxvq3ei894q
bxvq3ei894q
bxvq3ei894q
bxvq3ei894q
jtzhp8ti9s
jtzhp8ti9s
jtzhp8ti9s
jtzhp8ti9s
jtzhp8ti9s
jtzhp8ti9s
jtzhp8ti9s
To view investors' portfolios
Sign Up For Free
Arcellx Inc
▲ 229.17%
2
Close
Feb 18, 2024
Precision BioSciences
72.92%
▼ 94.60%
66
Buy
Feb 16, 2024
Tiziana Life Sciences
0.07%
▼ 74.87%
13
Sell
Feb 16, 2024
Passage Bio
0.01%
▼ 78.21%
19
Sell
Feb 16, 2024
Dole
1.84%
▼ 28.26%
22
Buy
Feb 16, 2024
Arbutus Biopharma
0.02%
▼ 4.06%
4
Sell
Feb 16, 2024
Fortress Biotech
0.23%
▼ 39.97%
5
Buy
Feb 16, 2024
Pfizer
0.17%
▲ 0.18%
1
Buy
Feb 16, 2024
Moderna
0.69%
▲ 4.39%
6
Buy
Feb 15, 2024
Novartis
5.98%
▼ 3.43%
2
Buy
Feb 15, 2024
MaxCyte
0.67%
▼ 8.47%
1
Buy
Feb 15, 2024
Playags
5.53%
▲ 5.38%
4
Buy
Feb 12, 2024
Greystone Housing Impact Investors
1.03%
▼ 2.17%
4
Buy
Feb 08, 2024
Intellia Therapeutics
0.84%
▼ 9.73%
4
Buy
Feb 05, 2024
Prime Medicine, Inc.
0.04%
▲ 2.89%
1
Buy
Jan 25, 2024
International Business Machines
1.19%
▲ 6.15%
3
Buy
Jan 22, 2024
TG Therapeutics
0.97%
▼ 6.68%
2
Buy
Jan 19, 2024
RegenXBio
0.14%
▲ 52.11%
1
Buy
Jan 12, 2024
Canada Goose Holdings
1.46%
▲ 1.97%
2
Buy
Jan 05, 2024
Ocular Therapeutix
5.81%
▲ 127.63%
3
Buy
Dec 22, 2023